High dose chemotherapy with hempopoietic rescue as primary treatment for metastatic breast cancer: A randomized trial
W.R. Bezwoda, L. Seymour & R.D. Dansey. High Dose Chemotherapy with Hempopoietic Rescue as Primary Treatment for Metastatic Breast Cancer: A Randomized Trial. Journal of Clinical Oncology 1995; 13: 2483-2489. Retracted in the Journal of Clinical Oncology 2001; 19: 2973.
W.R. Bezwoda, L. Seymour & R.D. Dansey. High Dose Chemotherapy with Hempopoietic Rescue as Primary Treatment for Metastatic Breast Cancer: A Randomized Trial. Journal of Clinical Oncology 1995; 13: 2483-2489. Retracted in the Journal of Clinical Oncology 2001; 19: 2973.
Disappointment and Deceit in High-Dose Chemotherapy Trials
J. Sprague Jones. Disappointment and Deceit in High-Dose Chemotherapy Trials. Breast Cancer Action Newsletter 2000; 59. Available at: http://www.bcaction. org/Pages/SearchablePages/2000Newsletters/Newsletter059A. html
High-dose chemotherapy for high-risk primary breast cancer; an on-site review of the bezwoda study
R.B. Weiss, R.M. Rifkin, F.M. Stewart, R.L. Theriault, L.A. Williams, A.A. Herman & R.A. Beveridge. High-dose Chemotherapy for High-Risk Primary Breast Cancer; an On-Site Review of the Bezwoda Study. Lancet 2000; 355: 999-103. P. Cleaton-Jones. Scientific Misconduct in a Breast Cancer Chemotherapy Trial: Response of the University of the Witwatersrand. Lancet 2000; 355: 1011-1012.
Scientific misconduct in a breast cancer chemotherapy trial: Response of the University of the Witwatersrand
R.B. Weiss, R.M. Rifkin, F.M. Stewart, R.L. Theriault, L.A. Williams, A.A. Herman & R.A. Beveridge. High-dose Chemotherapy for High-Risk Primary Breast Cancer; an On-Site Review of the Bezwoda Study. Lancet 2000; 355: 999-103. P. Cleaton-Jones. Scientific Misconduct in a Breast Cancer Chemotherapy Trial: Response of the University of the Witwatersrand. Lancet 2000; 355: 1011-1012.
An on-site audit of south african trial of high dose chemotherapy for metastatic breast cancer and associated publications
R.B. Weiss, G.G. Gill & C.A. Hudis. An On-Site Audit of South African Trial of High Dose Chemotherapy for Metastatic Breast Cancer and Associated Publications. Journal of Clinical Oncology 2001; 19: 2771-2779.
S. Lock & F. Wells, eds. London. BMJ Publishing Group 61-eds. London. BMJ Publishing Group 74
S. Evans. 1993. Statistical Aspects of the Detection of Fraud. In Fraud and Misconduct in Medical Research. S. Lock & F. Wells, eds. London. BMJ Publishing Group: 61-74.
International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Available at: http://www.icmje. org/index.html
M. Angell. Is Academic Medicine for Sale? The New England Journal of Medicine 2000; 342. Available at: http://content.nejm.org/cgi/content/full/342/ 20/1516
South African Department of Health. 2000. Guidelines for Good Practice in the Conduct of Clinical Trials in Human Participants in South Africa. Appendix E. Available at: http://196.36.153.56/doh/docs/policy/trials/trials_contents. html
The Council for International Organizations of Medical Sciences (CIOMS). 1991. International Guidelines for Ethical Review of Epidemiological Studies. Geneva. Available at: http://www.cioms.ch/frame_1991_texts_of_guidelines. htm
American College of Epidemiology. January 2000. American College of Epidemiology Ethics Guidelines. Available at: http://www.acepidemiology.org/ policystmts/EthicsGuide.htm
South African Department of Health. 2000. Guidelines for Good Practice in the Conduct of Clinical Trials in Human Participants in South Africa. Chapter 9.
International Committee of Medical Journal Editors, op. cit. note 9
International Committee of Medical Journal Editors, op. cit. note 9.
19
16444378427
Ibid
I b i d.
20
16344386136
Medical Research Council of South Africa. 2002. Guidelines on Ethics for Medical Research: General Principles. Available at: http://www.mrc.ac.za/ethics/ ethics.htm